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Abstract
Staphylococcus aureus is a potent biofilm former on host tissue and medical implants, and biofilm growth is a critical
virulence determinant for chronic infections. Recent studies suggest that many clinical isolates form polysaccharide-
independent biofilms. However, a systematic screen for defective mutants has not been performed to identify factors
important for biofilm formation in these strains. We created a library of 14,880 mariner transposon mutants in a S. aureus
strain that generates a proteinaceous and extracellular DNA based biofilm matrix. The library was screened for biofilm
defects and 31 transposon mutants conferred a reproducible phenotype. In the pool, 16 mutants overproduced
extracellular proteases and the protease inhibitor a2-macroglobulin restored biofilm capacity to 13 of these mutants. The
other 15 mutants in the pool displayed normal protease levels and had defects in genes involved in autolysis,
osmoregulation, or uncharacterized membrane proteins. Two transposon mutants of interest in the GraRS two-component
system and a putative inositol monophosphatase were confirmed in a flow cell biofilm model, genetically complemented,
and further verified in a community-associated methicillin-resistant S. aureus (CA-MRSA) isolate. Collectively, our screen for
biofilm defective mutants identified novel loci involved in S. aureus biofilm formation and underscored the importance of
extracellular protease activity and autolysis in biofilm development.
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Introduction
Staphylococcus aureus is a human commensal and the causative
agent of diverse acute and chronic bacterial infections. The
chronic infections persist and cause significant morbidity and
mortality to the patient due to the development of a recalcitrant
biofilm structure. Compared to the free-living (planktonic) state, S.
aureus living in biofilms exhibit significant differences in gene
expression and physiology [1], and the close proximity of
organisms may also allow cooperative metabolic functions,
promote horizontal gene transfer, and facilitate cell-to-cell
communication [2,3]. The most notorious biofilm characteristic
is their extraordinary resistance to antimicrobial killing [4]. In a
recent comparison, we observed a six-log difference in cell viability
in the presence of antibiotics of an S. aureus biofilm versus
planktonic cells [5].
Despite the important role of S. aureus biofilms in disease, our
understanding of the molecular mechanisms contributing to
biofilm formation is incomplete. Recent studies of S. aureus biofilm
development suggest that the extracellular matrix consists of
proteins, DNA, and/or polysaccharide (also called the polysac-
charide intercellular adhesin or PIA). In support of this proposal,
compounds capable of dissolving matrix components (proteases,
DNAse, or glycoside hydrolases) can disrupt established biofilms or
prevent the formation of a biofilm [5,6,7,8]. Recently, it has
become evident that emerging clinical S. aureus isolates are not
reliant on PIA for biofilm formation [7,9,10]. Protein-mediated
biofilm formation has emerged as a prominent alternative to PIA,
and many surface adhesins, such as Bap [11], Spa [12], FnBPA
and FnBPB [13], and SasG [14,15], have been implicated in this
divergent biofilm mechanism. Biofilms produced by these PIA-
independent strains are unaffected by polysaccharide-degrading
enzymes, such as dispersin B [6], or mutations in the ica gene locus
that generates PIA [1,5,7,13]. Therefore, we set out to uncover
PIA-independent mechanisms of biofilm formation.
Here we report the generation of a mariner transposon mutant
library of 14,880 mutants in a S. aureus strain that develops a
biofilm by a PIA-independent mechanism. This library was
screened for reduced biofilm formation in a microtiter assay and
numerous novel loci were identified. This work expands our
understanding of genetic factors controlling biofilm formation and
may provide potential targets for therapeutic intervention.
Results
Identification of mariner transposon mutants defective in
biofilm formation
To identify genes involved in PIA-independent biofilm
formation, we mutagenized S. aureus strain SH1000 using the
bursa aurealis (mariner) transposon mutagenesis system [16]. This
strain was chosen for mutagenesis and screening because it forms
PIA-independent biofilms and is readily amendable to genetic
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10146manipulation [5]. Preliminary testing of the mariner transposon
system in strain SH1000 was shown to be successful [10].
Altogether, a transposon mutant library of 14,880 mutants was
created and banked for further analysis.
Initial screening for biofilm formation in microtiter plates
yielded 91 mutants with a defect in attachment. Mutants with
severe growth defects were eliminated from further analysis and
the remaining potential biofilm mutants were reexamined for
reproducibility in the biofilm assay. Thirty-one mutants displayed
reproducible biofilm formation defects and arbitrary PCR and
sequencing was used to map the insertion location (Table 1).
Transposon insertions resulting in a biofilm phenotype were
mapped to a variety of genetic loci. Some of the loci, such as altA,
fmtA, graS, rsbU and rsbV have previously been shown to be
important in S. aureus biofilm formation [10,17,18,19]. The
remaining mutants had insertions in genes not previously
identified to be involved in biofilm formation.
Extracellular protease activity of biofilm mutants
Recent studies have demonstrated that protease activity can
have antibiofilm effects [5,7,20,21]. To determine if any of the
biofilm defective mutants produced increased levels of extracellu-
lar protease activity, we assayed protease levels in culture
supernatants of the biofilm mutants (Fig. 1). We found that 16
of the 31 transposon mutants displayed an increase in protease
activity in cell free supernatants. We hypothesized that the
increase in extracellular protease production could be the cause of
the biofilm defect in these mutants. To test this hypothesis, the
general protease inhibitor a2-macroglobulin was added to mutant
strains from the beginning of biofilm growth [15]. The addition of
Table 1. Biofilm defective mutants.
Mutant #
a 8325 ORF
b
Nucleotide
Insertion #
Gene
Name
b Description
b
% Biofilm
formation
c
12 D3 2147 2020811 Hypothetical membrane protein 52+/27
42 F6 19 23385 purA Adenylosuccinate synthetase 51+/24
46 E1 02667 2452369 gltT proton/sodium-glutamate symport protein 53+/28
46 H7 718 702698 Hypothetical membrane protein 49+/25
49 F10 2444 2268603 opuD Osmoprotectant transporter 55+/24
51 G5 998 970896 fmtA autolysis related protein 31+/27
52 E4 998 970888 fmtA autolysis related protein 35+/25
54 C2 2444 2268611 opuD Osmoprotectant transporter 54+/27
57 B10 998 970904 fmtA autolysis related protein 34+/24
62 F10 998 970842 fmtA autolysis related protein 49+/28
79 B5 2000 1910805 glutamate-1-semialdehyde-2,1-aminomutase 66+/27
123 D2 621 613148 Conserved Hypothetical 52+/24
128 B10 1430 1368060 Glucose group IIA phosphotransferase protein 61+/26
130 G5 994 964397 atlA Bifunctional autolysin precursor 34+/23
132 G7 994 964408 atlA Bifunctional autolysin precursor 31+/25
3 C5 2301 2133979 rsbU Sigma B locus 26+/27
19 C7 83 90302 sbnI Siderophore synthesis 55+/24
37 C9 666 653778 graS membrane sensor histidine kinase 27+/26
37 G12 2300 2133287 rsbV Sigma B locus 31+/29
51 F7 1589 1515687 Segregation and condensation protein A or B 54+/26
52 H3 2418 2247610 Drug resistance transporter 52+/26
60 G7 1055 1022985 imp Inositol monophosphatase 39+/28
63 G6 1734 1637360 ATPase family 57+/27
64 G10 1055 1022984 imp Inositol monophosphatase 35+/24
83 F3 1721 1624961 Conserved Hypothetical 58+/29
90 H11 149 160552 N-acetyl-glutamyl-phosphate reductase 61+/28
114 E5 1066 1034172 Protoheme IX farnesyltransferase 57+/27
116 G6 1066 1034170 Protoheme IX farnesyltransferase 60+/28
128 D3 75 80466 sbnA siderophore synthesis 59+/25
133 H10 2880 2653709 Glycosyltransferase 63+/26
141 A2 79 84941 sbnE siderophore synthesis 57+/27
aOrder of mutants listed matches the ordering in Figures 1 and 2.
bORF numbers, gene names, and descriptions are from the National Microbial Pathogen Data Resource web site (www.nmpdr.org).
cPercentages of biofilm formation for each mutant relative to wild type represent the means (+/2 standard deviations) from four independent experiments each
performed in triplicate.
doi:10.1371/journal.pone.0010146.t001
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protease overproducing mutants (blue bars, Fig. 2b). Recovery of
the rsbU and rsbV insertions with a2-macroglobulin supports our
previous report where the biofilm defect of a sigB deletion was
recovered with the same inhibitor [10]. The three protease
overproducing mutants that did not form a biofilm in the presence
of a2-macroglobulin had insertions in a two-component system
(graS, mutant 37 C9) or in a probable inositol monophosphate
phosphatase (hereafter the gene is called ‘‘imp’’, mutants 60 G7 &
64 G10). In mutants that displayed a wild-type level of
extracellular protease activity, the addition of a2-macroglobulin
had no effect. Collectively, these results indicate that extracellular
protease activity is an important contributor to the biofilm defect
in 13 of the biofilm mutants.
Extracellular nuclease activity of biofilm mutants
Evidence in many different bacterial species, including S. aureus
and CA-MRSA, indicates that extracellular DNA (eDNA) is an
important component of the biofilm matrix [6,8,9,22,23,24,25,26].
Consistent with the key role of eDNA, the expression and
extracellular activity of the S. aureus thermostable nuclease has
profound effects on biofilm maturation [6,8]. Based on these
results, we hypothesized that some mutants may be unable to form
biofilms due to increased nuclease expression. To address this
hypothesis, a phenotypic plate assay was employed to assess the
levels of extracellular nuclease activity in biofilm defective
mutants. After testing all 31 mutants, four mutants in the pool,
3C 5( rsbU), 37 G12 (rsbV), 60 G7 (imp) and 64 G10 (imp), had
increased levels of extracellular nuclease activity (Fig. 3). These
four mutants were also tested using a quantitative nuclease assay,
and the results confirmed the plate assay phenotypes (Fig. 3). The
increased nuclease activity of the rsbU and rsbV mutants is
consistent with microarray profiling of Sigma B defective strains
[27].
Autolysis levels of biofilm mutants
S. aureus biofilm matrix is composed in part by eDNA that has
been released by autolysis [8,23]. Therefore if lysis is altered, the
change could reduce the ability of S. aureus to effectively form a
biofilm. To test for this phenotype, we utilized an assay that
measures autolysis as a function of b-galactosidase release into
culture supernatants [23]. We focused on the 18 transposon
mutants in the pool of 31 unable to form a biofilm in the presence
of a2-macroglobulin (black and red bars, Fig. 2). Due to some
genes with multiple insertions (Table 1), this pool was reduced to
12 insertions in unique loci and each of these mutants was
transformed with plasmid pAJ22, which constitutively expresses
the lacZ gene. Cell free culture supernatants were assayed for b-
galactosidase activity at indicated time points. During a time
course, the autolysis profile of five mutants mirrored wild type
(data not shown), while seven of the 12 mutants showed significant
changes in b-galactosidase activity (Fig. 4). Four of these seven
mutants, 42 F6 (purA), 54 C2 (opuD), 123 D2 (hypothetical
membrane protein), and 132 G7 (atlA), all demonstrated reduced
autolysis compared to their isogenic parent. Conversely, three
mutants 51G5 (fmtA), 37 C9 (graS), and 60 G7 (imp), displayed an
increase in autolysis. Of these, the fmtA mutant showed high levels
of autolysis early in the time course (12–36 hrs, Fig. 4), while lysis
in the graS and imp mutants was more pronounced later in the time
course (36–72 hrs, Fig. 4). The altered ability of these mutants to
precisely control autolysis (and thus release of eDNA) may
contribute to their inability to effectively form biofilms.
graS and imp mutants are biofilm defective in a CA-MRSA
strain
Mutations in the graS and imp genes were chosen for further
study because of their unique combination of autolysis, nuclease,
and protease phenotypes (Figs. 2, 3, 4). To assess the biofilm
maturation phenotypes in a flowing environment, the graS and imp
transposon mutants were grown in a flow cell biofilm model. As
shown in Figure 5A, both the graS mutant (37 C9) and the imp
mutant (60 G7) displayed profound defects in biofilm maturation
Figure 1. Extracellular protease activity of biofilm mutants.
Protease activity in cell-free supernatants from cultures grown in TSB for
12 hours was measured with Azocoll reagent as described in Materials
and Methods. Supernatant protease activity of the wild-type strain
(SH1000) was set to 1 as a reference. The graph shows the mean of
three samples; error bars show standard deviation. Blue bars indicate
mutants that show consistently higher levels of protease activity.
doi:10.1371/journal.pone.0010146.g001
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complemented by expressing the wild-type gene from a plasmid.
To address potential issues of strain-to-strain variation, the graS
and imp transposon insertions were transduced into a CA-MRSA
isolate called LAC* (erythromycin sensitive variant of LAC, see
Materials and Methods). The LAC* strain is a member of the
USA300 lineage [28], and previous studies have demonstrated
that the strain is a robust biofilm former on diverse surfaces [9,10].
The graS and imp insertions were transduced into the LAC* strain
and growth in a flow cell biofilm model was compared to wild type
(Fig. 5B). Similar to the SH1000 genetic background, the LAC*
graS and imp mutants were defective in biofilm maturation, and
again the biofilm phenotype could be complemented through
plasmid expression. These results demonstrate that the graS and
imp mutant biofilm phenotypes are consistent across multiple in
vitro models of biofilm maturation and the phenotype is conserved
in a clinical isolate.
Discussion
The ability of S. aureus to form biofilms is an important virulence
factor in many persistent infections [3,29]. Recently, it has been
shown that some S. aureus clinical isolates do not require
polysaccharide production to form a biofilm [1,7,9,10]. To the
best of our knowledge, this type of polysaccharide-independent
biofilm (termed PIA-independent) has not been systematically
investigated through transposon mutagenesis. We created and
screened a mariner transposon mutant library in a PIA-
independent strain and identified 31 insertions that displayed
reproducible biofilm defects. Our screen was large but not
saturating, as some loci known to be biofilm deficient in the
SH1000 background, such as sarA and dltA, were not identified
(data not shown).
To understand the 31 identified biofilm mutants in more detail,
various aspects of biofilm matrix production and breakdown were
Figure 2. Assessment of biofilm formation in transposon mutants. Microtiter biofilm assays were performed in the absence (A) or presence
(B) of the protease inhibitor a2-macroglobulin in triplicate, and the percentages of biofilm formation for each mutant relative to that of the wild type
are shown. Error bars show standard deviation. Color coding is as follows: black bars indicate mutants with normal extracellular protease activity, blue
bars indicate high protease activity and biofilm recovery with a2-macroglobulin, and red bars indicate the graS (37 C9) and imp (60 G7, 64 G10)
mutations that did not recover with a2-macroglobulin.
doi:10.1371/journal.pone.0010146.g002
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material in the matrix [5,6,7], we examined the contribution of
secreted proteases to the biofilm phenotype. Almost half of the
mutant pool displayed an increased level of protease activity in
culture supernatants (Fig. 1), and the biofilm phenotype of this
subset could be mostly restored with the general inhibitor a2-
macroglobulin (Fig. 2). This finding suggests a critical and perhaps
underappreciated role of the extracellular proteases in biofilm
maturation. In recent reports, high levels of protease activity have
been linked to biofilm phenotypes in sigB and sarA mutants
[10,20,21], and this activity has an additional role in biofilm
dispersal [5]. Numerous potential targets for the proteases have
been investigated, including surface adhesins BAP [21,30], Spa
[12], SasG [14,15], FnBPA, and FnBPB [13], and the murein
hydrolyases have also been suggested as a target [10].
Along with proteins in the S. aureus biofilm matrix, growing
evidence indicates eDNA is an important matrix material [8,9,23].
Microarray data has indicated that the nuc gene is down-regulated
during biofilm formation as compared to planktonic cultures [1],
suggesting a disregulation of nuclease could lead to defects in
biofilm formation. Transposon insertions in rsbU, rsbV, and imp
genes resulted in increased nuclease activity in culture superna-
tants (Fig. 3). Insertions in rsbU and rsbV eliminate SigB activity
[10], and sigB mutants are known to have increased nuc gene
expression [27]. However, the significance of this phenotype is not
clear as higher levels of protease activity have been linked to the
biofilm phenotype [10], which is supported by the recovery of the
rsbU and rsbV mutants with a2-macroglobulin (Fig. 2). Increased
nuclease activity may be a factor in the imp mutant biofilm
phenotype, but further analysis will be necessary to demonstrate a
connection.
In order to release eDNA into the environment, S. aureus cells
lyse and are able to incorporate the eDNA into the biofilm matrix
[8,23]. This autolysis event is a complex and tightly controlled
process that involves regulation of holins, antiholins and murein
hydrolase activity [31]. In the pool of biofilm-defective mutants,
seven displayed altered autolysis levels compared to the isogenic
parent. Of this subset, four displayed a reduction in autolysis
activity, suggesting they failed to release adequate amounts of
eDNA as biofilm matrix material. As anticipated, mutations in the
major murein hydrolase, atlA, possessed low levels of autolytic
activity. Mutants in atlA in S. aureus and Staphylococcus epidermidis
(called atlE) have previously been shown to have defects in biofilm
formation [17,32], and the expression of atlA is known to increase
during biofilm growth [33]. In S. epidermidis, the reduction in
biofilm formation by atlE mutants has been attributed to the ability
of this protein to bind vitronectin, an abundant glycoprotein found
in serum [32]. Considering that no serum was present in our
biofilm growth conditions, we speculate that the biofilm defect in
S. aureus atlA mutants is due to decreased autolysis and DNA
release.
Three other transposon insertions in an osmoprotectant
transporter (OpuD homolog), purA, and a hypothetical membrane
protein (mutant 123 D2) also displayed decreased autolysis. The
OpuD-like protein has sequence similarity to a glycine-betaine
osmoprotectant transporter that is necessary for biofilm formation
in Vibrio cholerae [34]. The purA gene encodes for a putative
adenylosuccinate synthetase that is upregulated during biofilm
growth [1], and the purA knockout displayed the lowest level of
autolysis of tested mutants (Fig. 4). Studies in Bacillus cereus revealed
that a purA mutant is unable to effectively form biofilms or release
eDNA, and the expression of purA is upregulated in a biofilm
versus planktonically grown cells [35].
In contrast, transposon insertions in the genes fmtA, graS, and imp
displayed an overall increase in autolysis (Fig. 4). FmtA is an
autolysis and methicillin-resistance related protein that was
identified in screens for increased oxacillin sensitivity in the
presence of detergent [36]. Biochemical analysis demonstrated
that FmtA is a penicillin-binding protein that is resistant to b-
lactam inactivation [37], and the protein is known to localize to
the membrane and affect cell wall structure [38]. A previous
Figure 3. Extracellular nuclease activity of selected biofilm
defective mutants. Nuclease activity was measured as described in
Materials and Methods and plotted relative to SH1000 levels. For the
imp mutant, only the results of transposon mutant 60 G7 are shown.
Results with imp mutant 64 G10 were indistinguishable (data not
shown). Underneath the plotted nuclease activity results are represen-
tative images of colonies grown on methyl green DNase agar plates.
Clearing zones around the colonies is indicative of increased nuclease
activity. Error bars show standard deviation.
doi:10.1371/journal.pone.0010146.g003
Figure 4. Time course of autolysis in selected biofilm mutants.
Planktonic cultures of seven transposon mutants harboring plasmid
pAJ22, which expresses cytoplasmic b-galactosidase, were grown for
72 hrs. Every 12 hr during the time course samples were removed from
cultures and b-galactosidase activity in cell free supernatants was
measured (reported in Miller units). SH1000 with pAJ22 was included as
a control (shown as black squares). Results shown were the average of
two independent experiments done in triplicate and error bars show
standard deviation.
doi:10.1371/journal.pone.0010146.g004
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dependent strain identified the fmtA gene three different times
[18], suggesting that the FmtA protein is important across both
PIA-dependent and independent mechanisms of biofilm forma-
tion. The observation that both mutants that decrease autolysis
(altA, opuD, purA, 123 D2) and increase autolysis (fmtA, graS, imp)
have biofilm defects suggests that the timing of autolysis and the
accumulation of eDNA in the biofilm matrix may be critical in
biofilm development.
A transposon insertion in graS of the graRS (glycopeptide
resistance-associated) two-component regulatory system also
displayed an increase in autolysis (Fig. 4) and a pronounced
biofilm defect in both laboratory and CA-MRSA strains (Fig. 5).
Mutations in graRS are known to make S. aureus hyper-susceptible
to vancomycin [39], cationic antimicrobial peptides [40,41], and
cell lysis inducing agents [19,39], findings which correlate with our
observed increase in graS mutant autolysis. Genes encoding
proteins for D-alanylation of teichoic acids (dlt operon) and atlA
are induced by the GraRS system, and graRS mutants are reported
to have a microtiter-based biofilm defect [19]. The increase in graS
mutant autolysis over wild-type levels did not occur until late in the
time course (.24 hrs, Fig. 4), with the most significant increase
after 36 hrs. In the flow cell biofilms (Fig. 5), most S. aureus
attachment and preliminary biofilm formation is occurring in the
first 24 hr, suggesting that the reduced dlt and atlA expression are
the major contributors to the graS mutant biofilm phenotype.
The final mutant that displayed increased autolysis was a
transposon insertion in the imp gene, which is predicted to encode
for an inositol monophosphatase, an enzyme capable of dephos-
phorylating inositol phosphate to inositol. Mutations in imp
displayed nuclease overproduction (Fig. 3) and a pronounced
biofilm defect (Fig. 5) that was conserved in a CA-MRSA strain.
Inositol is an important signaling molecule in eukaryotes, but its
role in bacteria is not well understood [42]. The altered nuclease
and autolysis levels suggest a potential regulatory role for the imp
gene in S. aureus. Interestingly, an inositol monophosphatase
mutant (suhB) was found in a search for biofilm defective mutants
in Burkholderia cepacia [43], suggesting this gene may play an
important role in biofilm formation in diverse bacterial species.
Further analysis will be necessary to define the role of the imp gene
in biofilm maturation and determine the significance of the
observed nuclease and autolysis phenotypes.
Five remaining mutants did not fall into the categories of
displaying increased protease or nuclease activity, or having an
Figure 5. Flow cell biofilm formation of graS and imp mutants in different strain backgrounds. S. aureus strains SH1000 (A) and LAC* (B),
and graS and imp mutations in each strain, were grown in a flow cell apparatus for two days. A z series of images was obtained with CLSM,
reconstructed with Volocity software, and each side of a grid square is 20 mm in the image reconstruction. The addition of a complementing plasmid
containing either the graRS or imp genes is shown in the last column.
doi:10.1371/journal.pone.0010146.g005
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potential membrane proteins (mutants 12 D3 and 46 H7), a
glutamate transporter (gltT), a glutamate-1-semialdehyde-2,1-
aminomutase, and a glucose group IIA phosphotransferase
protein. Microarray studies have demonstrated an upregulation
of expression in gltT during PIA-dependent biofilm growth,
potential evidence of a link between GltT and biofilms [44]. At
this time the roles for these five genes and their encoded proteins
in biofilm formation is unknown.
Overall, the work presented here confirms published reports
and provides new insight into genetic loci required for PIA-
independent biofilm formation. Over half of the biofilm defective
mutants expressed high levels of extracellular protease activity, and
a significant portion of the mutant pool either overproduced
nuclease or had altered cell lysis phenotypes, indicating a major
biofilm role for proteins and eDNA in the absence of
exopolysaccharide. Moving forward, it will be important to assess
how these various identified factors collaborate during the biofilm
maturation mechanism.
Materials and Methods
Strains and growth conditions
The bacterial strains used in this study are described in Tables 1
and 2. Strains of Escherichia coli were grown in Luria-Bertani broth
or Luria agar plates, and growth medium was supplemented with
ampicillin (100 mg/ml) or chloramphenicol (10 mg/ml) as needed
for maintenance of plasmids. Strains of S. aureus were grown in
tryptic soy broth (TSB) or tryptic soy agar (TSA). For selection of
chromosomal markers or maintenance of plasmids, S. aureus
antibiotic concentrations were (in mg/ml) the following: chloram-
phenicol (Cam), 10; erythromycin (Erm), 10; and tetracycline
(Tet), 5. All reagents were purchased from Fisher Scientific
(Pittsburg, PA) and Sigma (St. Louis, MO) unless otherwise
indicated.
Strain LAC was made Erm sensitive by serial passage in TSB in
order to cure the strain of the native plasmid pUSA03 that confers
Erm resistance [45]. A single colony was picked and saved as Erm
sensitive strain AH1263, and hereafter this strain will be referred
to as LAC
*.
Recombinant DNA and genetic techniques
Restriction and modification enzymes were purchased from
New England Biolabs (Beverly, MA). All DNA manipulations were
performed in E. coli strain BW25141 [46]. Oligonucleotides were
synthesized at Integrated DNA Technologies (Coralville, IA).
Nonradioactive sequencing was performed at the DNA sequenc-
ing facility at the University of Iowa. Plasmids were transformed
into S. aureus RN4220 by electroporation and moved to other
strains using transduction by bacteriophage 80a as described
previously [47,48]. Chromosomal markers were moved between S.
aureus strains using bacteriophage 80a or 11 transduction.
Generation and mapping of transposon mutants
SH1000 was transformed with plasmids pFA545 and pBursa,
and mutagenesis was performed as described previously [10].
Transposon mutants with secondary agr defects were removed
from the pool by testing for AIP-I production as described
previously [49]. Mutants were banked in deep-well microtiter titer
plates in TSB with 10% glycerol and stored at –80uC. Transposon
insertion sites were mapped using arbitrary PCR [10].
Biofilm assays
Microtiter plate biofilms and flow cell biofilms were grown as
described previously [5]. For culture media, microtiter biofilms
were grown in 66% TSB supplemented with 0.2% glucose, and
flow cell biofilms were grown in 2% TSB supplemented with 0.2%
glucose. For protease inhibition in microtiter biofilms, cells were
added to the plate with a2-macroglobulin (final concentration,
0.25 units/ml; Roche). Confocal scanning laser microscopy
(CSLM) and image analysis was performed as described previously
[5]. Biofilms were treated with 330 nM Syto9 (LIVE/DEAD
BacLight Bacterial Viability Kit; Invitrogen, Carlsbad, CA)
15 min prior to visualization.
Protease and nuclease assays
Quantitative protease activity measurements were determined
using Azocoll (Calbiochem, San Diego, CA) reagent as described
previously [50]. Difco DNase test agar with methyl green (BD,
Franklin Lakes, NJ) was used to screen biofilm mutants for altered
nuclease production. Nuclease activity in culture supernatants was
measured as described by Heins et. al [51].
Autolysis assay
To determine autolysis activity, overnight cultures of each strain
harboring plasmid pAJ22 [52], were diluted to an OD at 600 nm
of 0.1 in TSB (no antibiotic) and grown at 37uC shaking at
200 rpm. At various time points, supernatants from each culture
were harvested by centrifugation. b-galactosidase activity in the
supernatants was determined as described [53] using o-nitrophe-
nyl-beta-d-galactopyranoside as the substrate and reported in
Miller units [54].
Plasmid construction
pCM1. Plasmid pCM1 was created to serve as a new
chloramphenicol resistant S. aureus expression vector. This
plasmid was constructed by moving the chloramphenicol
acetyltransferase gene into plasmid pAH15 [55] and eliminating
erythromycin resistance. The chloramphenicol acetyltrans-
ferase gene was amplified using oligonucleotides CLM-
329: GTTGTTGCTCAGGTAAAGGAGGCATATCAAATGAAC
Table 2. Strains and plasmids.
Strain or
plasmid Description
Source or
reference
Strains
E. coli strains
DH5a-E Cloning strain Invitrogen
BW25141 Cloning strain [46]
S. aureus strains
SH1000 sigB
+ derivative of NCTC8325-4 [56]
LAC CA-MRSA USA300-0114 [28]
AH1263 (LAC*) Erm-sensitive LAC This study
Plasmids
pAJ22 b-galactosidase expression plasmid [23]
pBursa Mariner hopping plasmid [16]
pFA545 Mariner transposase [16]
pCm1 S. aureus expression plasmid This study
pCm1-imp imp gene cloned into pCm1 This study
pCm1-graRS graRS genes cloned into pCm1 This study
doi:10.1371/journal.pone.0010146.t002
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TTAGGCCTATC and plasmid pAH5 [55] as template. The PCR
product was digested with BclI and Bpu10I and ligated to pAH15
digested with the same enzymes to create pCM1.
pCM1-imp. Plasmid pCM1-imp was created by cloning a
1081 base pair PCR product containing the imp gene and
promoter region into pCM1 that had been restriction digested
with HindIII and EcoRI. The oligonucleotides used to
generate the imp PCR product were: inositolREVecoRI (59-
GAGGAATTCACTGGTTTTATATTGGCGCGTG-39) and
inositiolFORhindIII (59-GAGAAGCTTTAGfAGTACCTCCT-
GTATAGTGT-39). The resulting pCM1-imp plasmid has the
imp gene with its native promoter controlling expression.
pCM1-graRS. Plasmid pCM1-graRS was created by cloning a
1751 base pair PCR product containing the graRS genes without
their native promoter into pCM1 that had been restriction
digested with KpnI and EcoRI. The oligonucleotides used to
generate the graRS PCR product were: graSkpn (59-AAAAAA-
GGTACCGTTTAAAATGACAAATTTGTC-39) and graReco-
R1 (59-AAAGAATTCTGATATTGGGTGATATGGATGC-39).
The resulting pCM1-graRS plasmid has the graRS genes with their
expression driven by the sarA promoter located on pCM1.
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